H.R. 7035 · 117th Congress
Biologics Market Transparency Act of 2022
- Stage
- In committee
- Sponsor
- Kathy Manning
- Introduced
- 2022-03-09
- Latest action
- 2022-03-10 · Referred to the Subcommittee on Health.
Summary
Biologics Market Transparency Act of 2022
This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.